ENOVIS CORP (ENOV) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:ENOV - US1940141062 - Common Stock
28.77 USD
+1.94 (+7.23%)
28.77 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to ENOV. ENOV was compared to 188 industry peers in the Health Care Equipment & Supplies industry. While ENOV is still in line with the averages on profitability rating, there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on ENOV.
1. Profitability
1.1 Basic Checks
In the past year ENOV was profitable.
ENOV had a positive operating cash flow in the past year.
In multiple years ENOV reported negative net income over the last 5 years.
ENOV had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -30.84%, ENOV is in line with its industry, outperforming 43.62% of the companies in the same industry.
Looking at the Return On Equity, with a value of -67.66%, ENOV is in line with its industry, outperforming 45.21% of the companies in the same industry.
With a decent Return On Invested Capital value of 0.12%, ENOV is doing good in the industry, outperforming 65.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROIC | 0.12% |
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ENOV has a Operating Margin of 0.25%. This is in the better half of the industry: ENOV outperforms 65.43% of its industry peers.
ENOV's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 57.19%, ENOV is in line with its industry, outperforming 55.32% of the companies in the same industry.
ENOV's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% |
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
2. Health
2.1 Basic Checks
ENOV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ENOV has been increased compared to 1 year ago.
Compared to 5 years ago, ENOV has more shares outstanding
The debt/assets ratio for ENOV is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.78, we must say that ENOV is in the distress zone and has some risk of bankruptcy.
ENOV has a Altman-Z score (0.78) which is in line with its industry peers.
ENOV has a debt to FCF ratio of 59.72. This is a negative value and a sign of low solvency as ENOV would need 59.72 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 59.72, ENOV is doing good in the industry, outperforming 66.49% of the companies in the same industry.
A Debt/Equity ratio of 0.66 indicates that ENOV is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.66, ENOV is doing worse than 66.49% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Altman-Z | 0.78 |
ROIC/WACC0.02
WACC7.24%
2.3 Liquidity
A Current Ratio of 2.22 indicates that ENOV has no problem at all paying its short term obligations.
ENOV has a worse Current ratio (2.22) than 60.64% of its industry peers.
A Quick Ratio of 1.16 indicates that ENOV should not have too much problems paying its short term obligations.
ENOV has a worse Quick ratio (1.16) than 71.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 |
3. Growth
3.1 Past
ENOV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.14%, which is quite impressive.
ENOV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.18% yearly.
ENOV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.57%.
ENOV shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.73% yearly.
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
3.2 Future
ENOV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.19% yearly.
The Revenue is expected to grow by 8.87% on average over the next years. This is quite good.
EPS Next Y12.58%
EPS Next 2Y12.38%
EPS Next 3Y13.12%
EPS Next 5Y23.19%
Revenue Next Year7.28%
Revenue Next 2Y6.83%
Revenue Next 3Y6.79%
Revenue Next 5Y8.87%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 8.64, the valuation of ENOV can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of ENOV indicates a rather cheap valuation: ENOV is cheaper than 95.21% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ENOV to the average of the S&P500 Index (25.45), we can say ENOV is valued rather cheaply.
A Price/Forward Earnings ratio of 8.05 indicates a reasonable valuation of ENOV.
Based on the Price/Forward Earnings ratio, ENOV is valued cheaper than 96.28% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ENOV to the average of the S&P500 Index (34.46), we can say ENOV is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.64 | ||
| Fwd PE | 8.05 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ENOV is valued cheaper than 89.36% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ENOV indicates a somewhat cheap valuation: ENOV is cheaper than 70.74% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 72.24 | ||
| EV/EBITDA | 9.61 |
4.3 Compensation for Growth
ENOV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ENOV's earnings are expected to grow with 13.12% in the coming years.
PEG (NY)0.69
PEG (5Y)N/A
EPS Next 2Y12.38%
EPS Next 3Y13.12%
5. Dividend
5.1 Amount
ENOV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
28.77
+1.94 (+7.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners121.31%
Inst Owner Change-2.39%
Ins Owners1.19%
Ins Owner Change2.68%
Market Cap1.64B
Revenue(TTM)2.23B
Net Income(TTM)-1.37B
Analysts83.75
Price Target52.79 (83.49%)
Short Float %13.73%
Short Ratio9.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.55%
Min EPS beat(2)7.76%
Max EPS beat(2)13.35%
EPS beat(4)4
Avg EPS beat(4)8.22%
Min EPS beat(4)4.97%
Max EPS beat(4)13.35%
EPS beat(8)8
Avg EPS beat(8)7.21%
EPS beat(12)12
Avg EPS beat(12)8.15%
EPS beat(16)16
Avg EPS beat(16)8.66%
Revenue beat(2)0
Avg Revenue beat(2)-0.15%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-0.8%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)-0.09%
Revenue beat(8)2
Avg Revenue beat(8)-0.81%
Revenue beat(12)4
Avg Revenue beat(12)-0.8%
Revenue beat(16)5
Avg Revenue beat(16)-4.71%
PT rev (1m)-4.75%
PT rev (3m)-11.45%
EPS NQ rev (1m)-4.99%
EPS NQ rev (3m)-5.2%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)2.89%
Revenue NQ rev (1m)-1.02%
Revenue NQ rev (3m)-1.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.64 | ||
| Fwd PE | 8.05 | ||
| P/S | 0.74 | ||
| P/FCF | 72.24 | ||
| P/OCF | 7.58 | ||
| P/B | 0.81 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.61 |
EPS(TTM)3.33
EY11.57%
EPS(NY)3.57
Fwd EY12.42%
FCF(TTM)0.4
FCFY1.38%
OCF(TTM)3.8
OCFY13.2%
SpS39.07
BVpS35.35
TBVpS-8.37
PEG (NY)0.69
PEG (5Y)N/A
Graham Number51.47
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROCE | 0.15% | ||
| ROIC | 0.12% | ||
| ROICexc | 0.12% | ||
| ROICexgc | 0.34% | ||
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% | ||
| FCFM | 1.02% |
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-45.54%
ROICexc growth 3YN/A
ROICexc growth 5Y-43.8%
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
F-Score4
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Debt/EBITDA | 4.5 | ||
| Cap/Depr | 66.6% | ||
| Cap/Sales | 8.7% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 72.98% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 | ||
| Altman-Z | 0.78 |
F-Score4
WACC7.24%
ROIC/WACC0.02
Cap/Depr(3y)55.91%
Cap/Depr(5y)50.8%
Cap/Sales(3y)7.49%
Cap/Sales(5y)6.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
EPS Next Y12.58%
EPS Next 2Y12.38%
EPS Next 3Y13.12%
EPS Next 5Y23.19%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
Revenue Next Year7.28%
Revenue Next 2Y6.83%
Revenue Next 3Y6.79%
Revenue Next 5Y8.87%
EBIT growth 1Y-35.24%
EBIT growth 3YN/A
EBIT growth 5Y-48.51%
EBIT Next Year74.87%
EBIT Next 3Y29.81%
EBIT Next 5Y28.11%
FCF growth 1Y122.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y609.06%
OCF growth 3Y-31.69%
OCF growth 5Y-2.82%
ENOVIS CORP / ENOV FAQ
What is the ChartMill fundamental rating of ENOVIS CORP (ENOV) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ENOV.
Can you provide the valuation status for ENOVIS CORP?
ChartMill assigns a valuation rating of 8 / 10 to ENOVIS CORP (ENOV). This can be considered as Undervalued.
Can you provide the profitability details for ENOVIS CORP?
ENOVIS CORP (ENOV) has a profitability rating of 4 / 10.
What is the earnings growth outlook for ENOVIS CORP?
The Earnings per Share (EPS) of ENOVIS CORP (ENOV) is expected to grow by 12.58% in the next year.